Matt Hewitt
Stock Analyst at Craig-Hallum
(0.71)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SLP Simulations Plus | Maintains: Buy | 45 36 | 16.88 | 113.27% | 8 | Jun 13, 2025 | |
CSBR Champions Oncology | Maintains: Strong Buy | 8 12 | 7.72 | 55.44% | 4 | Mar 12, 2025 | |
BLFS BioLife Solns | Maintains: Strong Buy | 30 32 | 21.52 | 48.7% | 4 | Nov 13, 2024 | |
OMCL Omnicell | Maintains: Strong Buy | 45 64 | 29.43 | 117.47% | 5 | Oct 31, 2024 | |
LGND Ligand Pharmaceutica... | Maintains: Strong Buy | 135 140 | 114.18 | 22.61% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 10 | 1.69 | 491.72% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 30 | 20.61 | 45.56% | 3 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | n/a | n/a | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 16 | n/a | n/a | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | 2.19 | 219.63% | 1 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 207 200 | 123.48 | 61.97% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.7 | 488.24% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 5 2 | n/a | n/a | 2 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 3 2 | n/a | n/a | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 67 30 | 8.44 | 255.45% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 400 | 0.94 | 42453.19% | 1 | Jan 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 21 30 | n/a | n/a | 3 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | n/a | n/a | 1 | Jul 24, 2017 |